SCHEMBL14940277

SCHEMBL14940277

Cc1cccc(C2C(=O)c3cccnc3C2=O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
MAPT P10636 4/20 0.41
MAPK1 P28482 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP19A1 P11511 1/20 0.41
TP53 P04637 2/20 0.40
GAA P10253 2/20 0.40
TDP2 O95551 1/20 0.40
NSD2 O96028 1/20 0.40
ABL1 P00519 1/20 0.40
PLCG1 P19174 1/20 0.40
CES1 P23141 1/20 0.40
PAX8 Q06710 1/20 0.40
RIN1 Q13671 1/20 0.40
THRB P10828 1/20 0.40
BLM P54132 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21048546 0.81 MAPT (0.62) KMT2AMEN1MAPTMAPK1KDM4E
SCHEMBL14939315 0.81 MEN1 (0.63) KMT2AMEN1MAPTMAPK1KDM4E
SCHEMBL21048499 0.73 MAPT (0.42) KMT2AMEN1MAPTMAPK1KDM4E
SCHEMBL14939987 0.68 RAB9A (0.54) KMT2AMEN1MAPTKDM4ECYP19A1
SCHEMBL14939531 0.67 RAB9A (0.58) KMT2AMEN1MAPTMAPK1KDM4E
SCHEMBL14938913 0.67 MEN1 (0.68) KMT2AMEN1MAPTMAPK1KDM4E
SCHEMBL28946044 0.65 CYP19A1 (0.43) KMT2AMEN1MAPTCYP19A1HTR2B
SCHEMBL18462364 0.64 PTPRC (0.65) KMT2AMEN1MAPTGAATDP2
SCHEMBL2187789 0.64 ADORA1 (0.55) KMT2AMAPTKDM4ERAB9ANPC1
SCHEMBL14939560 0.64 RAB9A (0.61) KMT2AMEN1MAPTMAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013068785-A1 INDANONE AND INDANDIONE DERIVATIVES AND HETEROCYCLIC ANALOGS ACTELION PHARMACEUTICALS LTD (CH) 2013-05-16 WO disclosed